Atlas FDA

MEDSTONE STS(TM) LITHOTRIPTER

FDA premarket approval P870015/S027 · decided 1997-10-31

Approval details

PMA number
P870015
Supplement
S027
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
MEDSTONE STS(TM) LITHOTRIPTER
Generic name
Lithotriptor, extracorporeal shock-wave, urological
Applicant
Medstone Intl., Inc.
Date received
1997-10-06
Decision date
1997-10-31
Days to decision
25 days
Decision code
APRL
Product code
LNS
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Aliso Viejo, CA
Statement
Approval for revision of the labeling regarding the risk of hypertension following renal lithotripsy (consistent with the conclusions of your final postapproval study report).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MEDSTONE, UROPRO 2000, TOMOGRAPHIC OPTION (K013620)Medstone Intl., Inc.2002-01-22
STS-T LITHOTRIPTER, MODEL STS-T (K010900)Medstone Intl., Inc.2001-04-05
STS(TM) FLUOROSCOPIC IMAGING MODULE (K905278)Medstone Intl., Inc.1991-02-04